Sexually Transmitted Diseases
Prenatal Risk Assessment Software «ISIDA»
Allergy Diagnostics Reagents Kits
Alkor Bio Group has received a grant of Bortnik Fund on the Commercialization program
In April Alkor Bio Group has received a grant of Foundation for Assistance to Small Innovative Enterprises (FASIE) in the competition Commercialization III for the project Genetic diagnostic of cystic fibrosis based on microchip-technology.
Alkor Bio Group has launched 15 new allergens
In April 2016 Laboratory of Allergology completed the development and transferred to the production 15 new allergens, including 1 recombinant allergen component of carrot - rDau c 1 Carrot
Alkor Bio Group has developed kits for the identification of five mutations in the CYP21A2 gene associated with the development of congenital adrenal hyperplasia (CAH).
Alkor Bio Group has developed the DNA isolation kit from whole blood and tissue material without preliminary preparation of sample
Laboratory of Allergology of Alkor Bio Group has launched 18 new allergens.
Alkor-Bio © 2008 | For letters: 197110, Russia, St.Petersburg, box 243